Insmed, Inc. (INSM)
111.12
+2.53
(+2.33%)
USD |
NASDAQ |
Oct 02, 16:00
111.44
+0.32
(+0.29%)
After-Hours: 20:00
Insmed Total Return Level : 111.12 for Oct. 2, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 02, 2026 | 111.12 |
| October 01, 2026 | 108.59 |
| September 30, 2026 | 114.14 |
| September 29, 2026 | 115.63 |
| September 28, 2026 | 117.67 |
| September 25, 2026 | 117.83 |
| September 24, 2026 | 121.55 |
| September 23, 2026 | 118.34 |
| September 22, 2026 | 120.82 |
| September 21, 2026 | 121.00 |
| September 18, 2026 | 120.00 |
| September 17, 2026 | 123.98 |
| September 16, 2026 | 122.58 |
| September 15, 2026 | 119.92 |
| September 14, 2026 | 125.30 |
| September 11, 2026 | 129.41 |
| September 10, 2026 | 127.28 |
| September 09, 2026 | 128.80 |
| September 08, 2026 | 124.89 |
| September 04, 2026 | 126.29 |
| September 03, 2026 | 126.68 |
| September 02, 2026 | 126.63 |
| September 01, 2026 | 121.51 |
| August 31, 2026 | 121.82 |
| August 28, 2026 | 118.54 |
| Date | Value |
|---|---|
| August 27, 2026 | 121.39 |
| August 26, 2026 | 124.39 |
| August 25, 2026 | 123.89 |
| August 24, 2026 | 123.98 |
| August 21, 2026 | 125.77 |
| August 20, 2026 | 125.08 |
| August 19, 2026 | 130.66 |
| August 18, 2026 | 128.46 |
| August 17, 2026 | 128.32 |
| August 14, 2026 | 123.74 |
| August 13, 2026 | 126.33 |
| August 12, 2026 | 132.28 |
| August 11, 2026 | 132.57 |
| August 10, 2026 | 134.75 |
| August 07, 2026 | 131.10 |
| August 06, 2026 | 132.55 |
| August 05, 2026 | 99.02 |
| August 04, 2026 | 98.75 |
| August 03, 2026 | 98.45 |
| July 31, 2026 | 98.60 |
| July 30, 2026 | 101.49 |
| July 29, 2026 | 103.12 |
| July 28, 2026 | 104.13 |
| July 27, 2026 | 104.73 |
| July 24, 2026 | 106.92 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.95 |
| Biogen, Inc. | 219.88 |
| Gilead Sciences, Inc. | 212.13 |
| United Therapeutics Corp. | 541.70 |
| Vertex Pharmaceuticals, Inc. | 504.73 |